View Scopus Profile

Daniel Batlle

Professor, Medicine, Nephrology Division
Earle, del Greco, Levin Professorship in Nephrology/Hypertension, Medicine, Nephrology Division
Driskill Graduate Training Program in Life Sciences

Phone+1 312 908 8342
Emaild-batlle@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

2 Active
26 Finished

1 - 25 out of 28 results

Active
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
Batlle, D. & Wysocki, J.
AstraZeneca Pharmaceuticals LP
5/26/20 → 5/31/21
Project: Research project
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Batlle, D., Lavker, R. M., Peng, H. & Thaxton, C. S.
Kennedy Institute - National Eye Clinic
7/1/19 → 7/31/23
Project: Research project
Finished
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E., Batlle, D. & Wallia, A.
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/15/17 → 6/30/19
Project: Research project
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Molitch, M. E., Batlle, D., Huang, W. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
Urinary Renin Angiotensin System in Diabetes
Molitch, M. E., Rademaker, A. W., Batlle, D. & Wysocki, J.
National Institute of Diabetes and Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Molitch, M. E., Batlle, D. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E., Batlle, D. & Wallia, A.
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/30/13 → 8/31/17
Project: Research project
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
Batlle, D.
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/09 → 8/31/14
Project: Research project
Fellowship in Support of Molecular Regulation of Soluble RAGE and Implications for TID Complications
Batlle, D.
JDRF International
12/1/08 → 2/28/10
Project: Research project
Nocturnal Hypertension in Type 1 Diabetes
Batlle, D.
JDRF International
10/1/08 → 9/30/13
Project: Research project
Fellowship in Support of Melatonin in Type I Diabetics with Nocturnal Hypertension
Batlle, D.
JDRF International
9/1/08 → 8/31/10
Project: Research project
Prot# 20070664: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with Chronic Kidney Disease on Hemodialysis with Hyperphosphatemia
Schlueter, W. A. & Batlle, D.
Fresenius Medical Care North America, Amgen, Inc.
5/12/08 → 5/12/11
Project: Research project
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
Batlle, D. & Wysocki, J.
JDRF International
12/1/07 → 6/30/11
Project: Research project
Nocturnal Hypertension and Prevention of Microalbu
Batlle, D.
King Pharmaceuticals Research and Development, Inc.
10/30/07 → 10/30/12
Project: Research project
Prot# 156-04-251: A Phase 3, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Arm Trial to Determine Long-Term Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease
Batlle, D., Ghossein, C. & Tuazon, J. A.
Parexel, Otsuka Maryland Research Institute, Inc.
9/4/07 → 9/4/10
Project: Research project
The Effect of Telmisartan on ACE2 in Diabetic Kidney
Batlle, D.
Boehringer Ingelheim International GmbH
1/1/07 → 1/1/09
Project: Research project
Prot# 20050182: EVOLVE: Evaluation of Cinacalcet HCI Therapy to Lower CardioVascular Events
Schlueter, W. A., Batlle, D. & Tuazon, J. A.
Fresenius Medical Care North America, Amgen, Inc.
11/3/06 → 5/1/12
Project: Research project
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
Molitch, M. E., Molitch, M. E., Molitch, M. E., Batlle, D. & Welty, L. J.
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/06 → 6/30/13
Project: Research project
Medical Education Grant: Center of Excellence in Chronic Kidney Disease (CKD) {Chicago Nephrology Day}
Batlle, D.
Abbott Laboratories
10/19/05 → 10/18/08
Project: Research project
Prot# 20040259: A Randomized, Open-Label Study to Assess the Safety of Epoetin Alfa Manufactured by Deep Tank Technology and Epoetin alfa Manufactured by Roller Bottle Technology in Subjects with Chronic Kidney Disease Not on Dialysis
Batlle, D. & Ghossein, C.
Amgen, Inc.
8/16/05 → 9/10/07
Project: Research project
Calculated GFR in Subjects Undergoing Management of Anemia Associated with Chronic Kidney Disease
Batlle, D.
Ortho Biotech Clinical Affairs, LLC
7/22/05 → 7/22/06
Project: Research project
Prot# AMG 073 20020390: TARGET: Treatment Strategies to Achieve Recommended K/DOQI Goals in ESRD Patients on Cinacalcet
Schlueter, W. A., Batlle, D. & Paparello, J. J.
Renal Care Group, Inc., Amgen, Inc.
7/20/05 → 10/20/05
Project: Research project
Renal ACE and ACE2 in Diabetic Mice
Batlle, D.
American Diabetes Association
7/1/05 → 6/30/08
Project: Research project
Prot# 20040268: An Open-Label, Single-Arm Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology in Subjects with Chronic Kidney Disease Receiving Dialysis
Schlueter, W. A. & Batlle, D.
Renal Care Group, Inc., Amgen, Inc.
6/29/05 → 9/10/07
Project: Research project
Mechanisms of Nocturnal Hypertension in Type I Diabetes
Batlle, D.
JDRF International
11/1/04 → 4/30/07
Project: Research project